Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial

Attempts to develop a drug treatment for female sexual interest/arousal disorder have so far been guided by the principle of ‘one size fits all’, and have failed to acknowledge the complexity of female sexuality. Guided by personalized medicine, we designed two on-demand drugs targeting two distinct...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuiten, Adriaan, Michiels, Frits, Böcker, Koen BE, Höhle, Daniël, van Honk, Jack, de Lange, Robert PJ, van Rooij, Kim, Kessels, Rob, Bloemers, Jos, Gerritsen, Jeroen, Janssen, Paddy, de Leede, Leo, Meyer, John-Jules, Everaerd, Walter, Frijlink, Henderik W, Koppeschaar, Hans PF, Olivier, Berend, Pfaus, James G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Special Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052493/
https://www.ncbi.nlm.nih.gov/pubmed/30016917
http://dx.doi.org/10.1177/1745506518788970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052493/
https://www.ncbi.nlm.nih.gov/pubmed/30016917
http://dx.doi.org/10.1177/1745506518788970

Ejemplares similares